O. Ragy

Unraveling Primary Membranous Nephropathy Using Proteogenomic Studies

P. Hamilton, D. Kanigicherla, O. Ragy, 2021, Urinary Tract Infection and Nephropathy - Insights into Potential Relationship [Working Title].

Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?

P. Brenchley, Alison Smith, V. Rautemaa, 2023, PloS one.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy

A. Khwaja, Anirudh Rao, D. Kanigicherla, 2023, Kidney international reports.

Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with Cyclophosphamide and Steroid-Based Regimen

S. Mitra, P. Hamilton, D. Kanigicherla, 2023, Glomerular diseases.